These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9312408)

  • 1. [Dichotomy between cholesterol-lowering drugs in clinical trials and practice. Experience of the DiSCO Project (District of Serra Community Control of Chronic Degenerative Diseases)].
    Volpe R; Angelico F; Ricci G; Urbinati G
    Cardiologia; 1997 Aug; 42(8):815-25. PubMed ID: 9312408
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management.
    Leitersdorf E
    Int J Clin Pract; 2002 Mar; 56(2):116-9. PubMed ID: 11926698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Statins: from hypocholesteremic drugs to antiatherogenic agents].
    Manzoli A; Patti G; D'Ambrosio A; Montesanti R; Calabrese V; Abbate A; Gioia G; Di Sciascio G
    Clin Ter; 2001; 152(5):307-13. PubMed ID: 11794851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anion exchange resin].
    Nakaya N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():642-9. PubMed ID: 11347147
    [No Abstract]   [Full Text] [Related]  

  • 6. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 7. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol lowering drugs.
    Amarasingham R
    N Z Med J; 1990 Mar; 103(886):138. PubMed ID: 2181355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ezetimib].
    Meyer Zu Schwabedissen H; Kroemer HK
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2038-40. PubMed ID: 15386207
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized clinical trials and recent patterns in the use of statins.
    Wang TJ; Stafford RS; Ausiello JC; Chaisson CE
    Am Heart J; 2001 Jun; 141(6):957-63. PubMed ID: 11376310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1329-30. PubMed ID: 15297284
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Comans ML
    Ned Tijdschr Geneeskd; 2001 Feb; 145(5):244. PubMed ID: 11219155
    [No Abstract]   [Full Text] [Related]  

  • 14. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering and vascular reactivity in relation to coronary heart disease.
    de Divitiis M; Rubba P
    Nutr Metab Cardiovasc Dis; 1999 Jun; 9(3):133-42. PubMed ID: 10464786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Campaign against arteriosclerosis. Inhibition of cholesterol absorption in the future?].
    MMW Fortschr Med; 2002 Sep; 144(35-36):50-1. PubMed ID: 12380357
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventive cardiology.
    Reeves WC
    Med Sect Proc; 1989; ():29-37. PubMed ID: 2701587
    [No Abstract]   [Full Text] [Related]  

  • 20. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM; Kuller LH
    Circulation; 2002 Jan; 105(2):136-9. PubMed ID: 11790688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.